Setu Shah

As a member of Sg2’s Intelligence team, Setu develops oncology thought leadership to help members navigate the current and future landscape of cancer care. She translates the impact of national trends, emerging drugs and therapeutics, and service distribution into strategic and business development considerations for health system leaders. Setu frequently collaborates with experts across Sg2 and Vizient on topics related to pharmacy and radiopharmaceutical therapy/theranostics. Prior to joining Sg2, she led project management and process improvement initiatives in the Department of Pediatric Newborn Medicine at Brigham and Women’s Hospital.